Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.

Alzheimer's disease is a neurodegenerative disorder that impairs neurocognitive functions. Acetylcholinesterase, Butyrylcholinesterase, Monoamine Oxidase B, Beta-Secretase, and Glycogen Synthase Kinase Beta play central roles in its pathogenesis. Current medications primarily inhibit AChE but f...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatima Zahra Guerguer, Amal Bouribab, El Mehdi Karim, Meriem Khedraoui, Fatiha Amegrissi, Yasir S Raouf, Abdelouahid Samadi, Samir Chtita
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0313411
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540283326169088
author Fatima Zahra Guerguer
Amal Bouribab
El Mehdi Karim
Meriem Khedraoui
Fatiha Amegrissi
Yasir S Raouf
Abdelouahid Samadi
Samir Chtita
author_facet Fatima Zahra Guerguer
Amal Bouribab
El Mehdi Karim
Meriem Khedraoui
Fatiha Amegrissi
Yasir S Raouf
Abdelouahid Samadi
Samir Chtita
author_sort Fatima Zahra Guerguer
collection DOAJ
description Alzheimer's disease is a neurodegenerative disorder that impairs neurocognitive functions. Acetylcholinesterase, Butyrylcholinesterase, Monoamine Oxidase B, Beta-Secretase, and Glycogen Synthase Kinase Beta play central roles in its pathogenesis. Current medications primarily inhibit AChE but fail to halt or reverse disease progression due to the multifactorial nature of Alzheimer's. This underscores the necessity of developing multi-target ligands for effective treatment. This study investigates the potential of phytochemical compounds from Moroccan medicinal plants as multi-target agents against Alzheimer's disease, employing computational approaches. A virtual screening of 386 phytochemical compounds, followed by an assessment of pharmacokinetic properties and ADMET profiles, led to the identification of two promising compounds, naringenin (C23) and hesperetin (C24), derived from Anabasis aretioides. These compounds exhibit favourable pharmacokinetic profiles and strong binding affinities for the five key targets associated with the disease. Density functional theory, molecular dynamics simulations, and MM-GBSA calculations further confirmed their structural stability, with a slight preference for C24, exhibiting superior intermolecular interactions and overall stability. These findings provide a strong basis for further experimental research, including in vitro and in vivo studies, to substantiate their potential efficacy in Alzheimer's disease.
format Article
id doaj-art-cecaeb24dcb34162a01d6a3a2b0045d2
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-cecaeb24dcb34162a01d6a3a2b0045d22025-02-05T05:31:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01201e031341110.1371/journal.pone.0313411Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.Fatima Zahra GuerguerAmal BouribabEl Mehdi KarimMeriem KhedraouiFatiha AmegrissiYasir S RaoufAbdelouahid SamadiSamir ChtitaAlzheimer's disease is a neurodegenerative disorder that impairs neurocognitive functions. Acetylcholinesterase, Butyrylcholinesterase, Monoamine Oxidase B, Beta-Secretase, and Glycogen Synthase Kinase Beta play central roles in its pathogenesis. Current medications primarily inhibit AChE but fail to halt or reverse disease progression due to the multifactorial nature of Alzheimer's. This underscores the necessity of developing multi-target ligands for effective treatment. This study investigates the potential of phytochemical compounds from Moroccan medicinal plants as multi-target agents against Alzheimer's disease, employing computational approaches. A virtual screening of 386 phytochemical compounds, followed by an assessment of pharmacokinetic properties and ADMET profiles, led to the identification of two promising compounds, naringenin (C23) and hesperetin (C24), derived from Anabasis aretioides. These compounds exhibit favourable pharmacokinetic profiles and strong binding affinities for the five key targets associated with the disease. Density functional theory, molecular dynamics simulations, and MM-GBSA calculations further confirmed their structural stability, with a slight preference for C24, exhibiting superior intermolecular interactions and overall stability. These findings provide a strong basis for further experimental research, including in vitro and in vivo studies, to substantiate their potential efficacy in Alzheimer's disease.https://doi.org/10.1371/journal.pone.0313411
spellingShingle Fatima Zahra Guerguer
Amal Bouribab
El Mehdi Karim
Meriem Khedraoui
Fatiha Amegrissi
Yasir S Raouf
Abdelouahid Samadi
Samir Chtita
Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.
PLoS ONE
title Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.
title_full Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.
title_fullStr Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.
title_full_unstemmed Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.
title_short Moroccan natural products for multitarget-based treatment of Alzheimer's disease: A computational study.
title_sort moroccan natural products for multitarget based treatment of alzheimer s disease a computational study
url https://doi.org/10.1371/journal.pone.0313411
work_keys_str_mv AT fatimazahraguerguer moroccannaturalproductsformultitargetbasedtreatmentofalzheimersdiseaseacomputationalstudy
AT amalbouribab moroccannaturalproductsformultitargetbasedtreatmentofalzheimersdiseaseacomputationalstudy
AT elmehdikarim moroccannaturalproductsformultitargetbasedtreatmentofalzheimersdiseaseacomputationalstudy
AT meriemkhedraoui moroccannaturalproductsformultitargetbasedtreatmentofalzheimersdiseaseacomputationalstudy
AT fatihaamegrissi moroccannaturalproductsformultitargetbasedtreatmentofalzheimersdiseaseacomputationalstudy
AT yasirsraouf moroccannaturalproductsformultitargetbasedtreatmentofalzheimersdiseaseacomputationalstudy
AT abdelouahidsamadi moroccannaturalproductsformultitargetbasedtreatmentofalzheimersdiseaseacomputationalstudy
AT samirchtita moroccannaturalproductsformultitargetbasedtreatmentofalzheimersdiseaseacomputationalstudy